FDA green-lights tirzepatide, marketed as Zepbound, for chronic weight management
Originally developed for Type 2 diabetes, these medications have proven highly effective for treating obesity a chronic condition affecting more than 40% of U.S
Institutional Review Board Statement This research was approved by the local Ethic Committee (case number 380-59-10106-17-100/290) and by the Directorate of Veterinary (UP/I-322-01/15-01/22)
This reaction converts the reduced form of glutathione (GSH) into oxidized glutathione (GSSG), which is then reduced back to GSH by glutathione reductase (GR), using electrons from NADPH (Dringen and Arend, 2025)
You may be able to return to work as long as you keep from doing any strenuous activity
This trend was strongest among Gen Z, with 80% reporting fewer setbacks